Doctors and health scientists from the United States have been impressed with the Russian vaccine against Covid-19, Sputnik V in an online presentation from Moscow.
Scientists from Moscow’s Gamaleya National Research Center for Epidemiology and Microbiology have conducted the first online briefing on the main stages of Sputnik V vaccine development for American colleagues.
A hundred specialists from the Maimonides Medical Center in New York participated in the debate, the Russian Direct Investment Fund (RDIF) reported in a press release.
“More than 100 doctors and health professionals from the Maimonides Medical Center, one of the most respected medical institutions in the US, which has been at the forefront of the fight against the coronavirus pandemic since March 2020, showed great interest for the Russian Sputnik V vaccine during the first online briefing of its kind by Russian scientists from the Gamaleya Research Center, ”reads a message from Russia’s RDIF.
On September 9, the third phase of clinical trials of the drug began with the participation of 40,000 people.
Sputnik V, the world’s first coronavirus vaccine, was developed by the Gamaleya National Research Center for Epidemiology and Microbiology and was registered on August 11 in full compliance with international standards.
Among other data, Russian experts told their American colleagues about the results of clinical trials, as well as the progress of post-registration clinical trials, which are currently underway.
The head of the cardiology department of the Maimonides Medical Center, Professor Jacob Shani, is quoted by the Russian press as saying that the data presented by the Russian side “made a great impression” on the specialists of the New York institution.
“We read the post in The Lancet and it was also very impressive. The vaccine worked well in Phase I and II clinical trials, including antibodies and cellular immunity, and the side effects were minimal. This all sounds very encouraging, ”Shani was quoted as saying.
The doctor indicated that US specialists already know that the Russian vaccine “causes the formation of antibodies and is safe,” but now they must “confirm that it does protect against coronavirus infection.”
“I personally asked if any of the vaccinated volunteers got sick and the answer was no. I would very much like to know the results of the vaccination of larger groups ”, declared the expert.